Speed with confidence in delivery
Ibex™ Design is our offering for your preclinical and IND needs through to clinical phase I. It includes a pioneering gene-to-vial package, delivering GMP drug product for your clinical phase 1 trials within 12 months, with an option to supply tox drug product in 9 months. To ensure speed to your milestones, Lonza guarantees the timelines of product supplied*. To further increase predictability for you, we will keep a manufacturing slot reserved for your clinical resupply. Benefit from our proven GS Gene Expression System® bioprocess platform and a holistic development strategy with the endpoint in mind.
*For antibodies and antibody like molecules. From receipt of the gene sequence. Subject to terms and conditions.